Skip to main content
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Held by Funds

Track IKT — free
$1.32 +0.02 (+1.54%) At close · Nov 20 Q2 2024 earnings call transcript
Market Cap
$185.16M
Shares
140.27M
Volume · Nov 20 1.11M Avg daily vol (3M) 580.26K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of IKT by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 9.41% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 2.25% 3,156,959
Index ETFs 7.16% 10,044,069
Active ETFs 0.00% 0
Active funds 0.61% 851,558
Unclassified 0.03% 47,634
All registered funds 10.05% 14,100,220
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding IKT

83 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 83 positions
Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 109 filings 103 filers Visit website Investor relations